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Abstract
Nutrient balance in the human body is maintained through systemic signaling between different cells and tissues. Breaking
down this circuitry to its most basic elements and reconstructing the metabolic network in-vitro provides a systematic
method to gain a better understanding of how cross-talk between the organs contributes to the whole body metabolic
profile and of the specific role of each different cell type. To this end, a 3-way connected culture of hepatocytes, adipose
tissue and endothelial cells representing a simplified model of energetic substrate metabolism in the visceral region was
developed. The 3-way culture was shown to maintain glucose and fatty acid homeostasis in-vitro. Subsequently it was
challenged with insulin and high glucose concentrations to simulate hyperglycaemia. The aim was to study the capacity of
the 3-way culture to maintain or restore normal circulating glucose concentrations in response to insulin and to investigate
the effects these conditions on other metabolites involved in glucose and lipid metabolism. The results show that the
system’s metabolic profile changes dramatically in the presence of high concentrations of glucose, and that these changes
are modulated by the presence of insulin. Furthermore, we observed an increase in E-selectin levels in hyperglycaemic
conditions and increased IL-6 concentrations in insulin-free-hyperglycaemic conditions, indicating, respectively, endothelial
injury and proinflammatory stress in the challenged 3-way system.
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Introduction
The metabolic profile of healthy individuals is well known. For
example, after an overnight fast, healthy subjects retain normal
circulating glucose concentrations, high circulating FFAs and
glycerol, and low lactate levels [1]. After feeding, their glucose shows
a slight rise, which quickly returns to normal levels, circulating FFA
and glycerol concentrations drop, and lactate rises. In obese and
diabetic patients, whole body metabolism is deranged such that
normalmetabolicpatternsarealtered [2–5].Thedistortedmetabolic
profiles of individualswithmetabolicdiseaseshavebeen the subjectof
intensive in-vivo investigations on humans and animals as well as on
simple in-vitro monocultures. It is clear from in-vivo studies that an
organism’s nutritional status is communicated through metabolic
signaling by adipose tissue and the liver and perceived by all organs
[6]. Nutritional overload is characterized by alterations inmetabolic
profiles and impairments in insulin responsiveness. In-vitro studies
have provided a great deal of information on individual molecular
pathways in single cells, but cannot be used to investigate how cross-
talk between different tissues determines whole body metabolism.
Indeed, while the signalingmechanisms responsible for homeostasis,
inflammation and injury have been well studied at the local cellular
level, it is less clear how alterations in one cell or tissue are
communicated to other parts of the body.
A number of key organs in different locations interact to
maintain the systemic energy balance. They are linked by the
vascular network; a vital communication highway for metabolic
signaling between tissues. Besides hormonal signaling, interaction
between tissues is also mediated by the metabolites themselves,
even in the absence of insulin and glucagon [7–10]. Clearly, a
better understanding of the metabolic cross-talk among different
organs is essential in order to find the most appropriate
interventions to treat or prevent metabolic diseases.
To probe cross-talk between tissues and determine how it may
contribute to the whole body metabolic profile, we have designed a
modular bioreactor system to systematically reconstruct endoge-
nous metabolism in-vitro [11,12]. The system consists of
interconnected chambers, each of which houses a specific tissue
or organ of relevance to energetic substrate metabolism. The
chambers are linked together by the flow of a common medium,
much as the bloodstream connects different tissues or organs in the
body. By increasing the number of interactions and variables step-
wise in a properly scaled model, nutrient dynamics between organs
and their contribution to systemic metabolism can be investigated.
Thus, breaking down the metabolic circuitry to its most basic
elements and reconstructing the network in-vitro, the specific
contribution of each tissue in maintaining the energy balance can
be assessed. In addition, analysis of metabolic interactions among
different cell types can be used to gain insights about the ways that
different tissues are relevant in determining the overall metabolic
profile and explore how systemic signaling of nutrient balance is
maintained, or how it may be disrupted.
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To reduce the complexity of the system, hepatocytes, adipose
tissue and endothelial cells were the first building blocks used to
assemble an in-vitro metabolic model representing the central
abdomen. These 3 elements constitute a relevant portion of the
abdominal viscera and are amongst the first to sense the
presence of nutritional input after ingestion. The liver has a
central role in energetic substrate metabolism, and its multiple
metabolic functions are carried out by hepatocytes. It processes,
converts and substantially regulates all 3 energetic substrates:
fats, sugars and proteins. Hepatocytes are therefore a key
element in any in-vitro metabolic system. Adipose tissue is a key
regulator of energy related cross-talk in the body. and is
fundamental to the modulation of insulin sensitivity in skeletal
and hepatic tissue [13–15]. Far from being a passive fat storage
depot, adipose tissue integrates and outputs information on the
overall nutritional status in the body, messaging distant organs
through its impressive array of signaling molecules such as
TNF-a (tumor necrosis factor-a), IL-6 (interleukin-6), adiponec-
tin, leptin and lipoprotein lipases. Over-nutrition is in fact
associated with a state of chronic low grade adipose tissue
inflammation, which induces vascular dysfunction and a
consequent series of knock-on effects in other organs and tissues
[16,17]. The two are connected together by the vascular system,
which acts as an important modulator of metabolic signaling.
Indeed the endothelium is one of the first tissues to perceive the
presence of excess nutrient intake [6] as well as the first to
contact nutrients as they spill into the blood stream after
digestion. Other organs involved in nutrient metabolism, such as
the brain, kidneys, pancreas and muscular tissue can be added
as successive modules in order to increase the physiological
relevance of the in-vitro model as we increase our understand-
ing of metabolic communication in the system.
In a previous study we demonstrated that flow significantly
affects cellular metabolism of hepatocytes, endothelial cells and
adipose tissue, resulting in increased glucose uptake and an overall
increase in free fatty acid (FFA) and lactate release [18]. The so-
called building blocks were linked together, first in a 2-way
adipose-endothelial system and then in a 3-way adipose-endothe-
lial-hepatic connected culture [12]. In this study the 3-way culture
was challenged with conditions representing normoglycaemia and
hyperglycaemia by altering the composition of the common cell
culture medium. The 4 media and their in-vivo equivalents were:
a) Normal glucose – in which the cell culture medium contained a
nominal glucose concentration of 5.5 mM representing the fasting
state (FS); b) Normal glucose with insulin (65 pM) – medium
simulating the post absorptive resting state (PARS); c) High
glucose (20 mM) – hyperglycaemia in the absence of insulin,
representing diabetes type 1 (D1); d) High glucose with 65 pM
insulin – the hyperglycaemic state with inadequate glycaemic
control, simulating diabetes type 2 (D2).
In all experiments an array of soluble metabolites and signaling
molecules (glucose, FFA, triacylglycerides, alanine, lactate, glycer-
ol, E-selectin, TNF-a, IL-6, albumin) was assessed by withdrawing
small volumes of media from the circuit over 48 hours. The aim
was to assess the capacity of this culture system to maintain/
restore normal circulating metabolite concentrations while exam-
ining the effects of these conditions on other metabolites. Despite
its apparent simplicity, the 3-way model shows that an imbalance
of energetic substrates in the form of excess glucose, combined
with insufficient insulin, changes the overall equilibrium or
homeostasis of the in-vitro model and also induces general as well
as specific endothelial stress, demonstrating its capacity to
recapitulate salient features of systemic metabolism.
Materials and Methods
Cell/tissue Sources
All reagents were from Sigma-Aldrich (Sigma-Aldrich, Milan,
Italy) unless otherwise specified.
Omental adipose tissue (AT) from nondiabetic subjects free of
known metabolic diseases (see Ethics Statement) was treated with
collagenase type II in HBSS (Hank’s Balanced Salt Solution); the
partially digested tissue was placed on a 200 micron mesh filter
and rinsed with DMEM (Dulbecco’s Modified Eagle Medium) to
remove blood vessels. Floating partially digested AT was then
divided into aliquots and transferred to DMEM with 20% FBS
(Foetal Bovine Serum) ready for experiments. The partial digestion
allowed us to concentrate adipocytes without destroying the
collagen matrix, which is important for preserving the adipocytic
phenotype [19].
Human umbilical vein endothelial cells (ECs) from Promocell
(Heidelberg, Germany) were used to model the endothelium. The
cells were cultured in Endothelial Cell Growth Medium (ECGM,
PromoCell), composed of Endothelial Cell Basal Medium
(Promocell) supplemented with 10% FBS, 0.1 ng/mL epidermal
growth factor, 1.0 ng/mL basic fibroblast growth factor, 0.4%
endothelial cell growth supplement/heparin, 1.0 mg/mL hydro-
cortisone (Promocell), 100 U/mL penicillin and 100 mg/mL
streptomycin and used up to passage 4. The liver model was
based on hepatocellular liver carcinoma cells (HepG2 hepa-
toyctes), kindly provided by Dr. S. Quarta, Laboratory of
Molecular Hepatology, Department of Clinical and Experimental
Medicine, University of Padua [20]. This cell line retains most of
the endogenous metabolic functions of hepatocytes and was used
because of its stability with respect to primary hepatocytes. HepG2
cells (HEP) were grown in Eagle’s minimal essential medium
(EMEM, glucose 1 g/L) supplemented with 5% FBS, 1%
nonessential amino acids, 1% EMEM vitamins, 2 mM L-
glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin
and used up to passage 22.
Experimental Design
To establish an in-vitro model of energetic substrate metabolism
we focused on the visceral compartment of the human abdomen to
determine physiologically relevant cell ratios. Cell number based
allometric scaling was used to estimate the ratios of the 3 tissues in
the model. Since cell numbers are proportional to organ masses
and volumes, the allometric exponent for scaling cell numbers is
one and cell ratios are therefore preserved when downscaling.
Standard human data attributes 12% of human body mass to
adipose tissue, 6.28% of body mass to vascular tissue and 2% to
the liver [21]. In the internal region of the abdomen the liver
occupies almost 60% (mass and volume) while adipose tissue and
vascular tissue are assumed to maintain uniform distribution
throughout the body. The final hepatocyte: adipocyte:endothelial
cell ratio was thus estimated to be 10:2:1. Using our previous data
on cell proliferation, the number of cells added to each chamber at
the beginning of the experiments was calculated to reach this ratio
at the end of the 48 hour experiments [22].
The in-vitro model was assembled using a modular system in
which 3 different bioreactor chambers with respectively hepato-
cytes seeded on 3 D scaffolds, adipose tissue and endothelial cells
were connected together to form a closed loop 3-way culture
system. The hepatic and adipose tissue modules used were low-
shear stress, high-flow inter-connectable chambers (Quasi-VivoH,
Kirkstall Ltd, Sheffield, UK), while the module used for the
endothelial cell culture is a laminar flow chamber, LFC, described
in ref. [23]. Fluid dynamic modelling was performed during the
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bioreactor design phase to estimate the shear stress in the two
chambers. At the flow rate used in the experiments (250 mL/min),
the wall shear stress is 0.002 Pa in the LFC and 1025 Pa in the
Quasi-Vivo. This flow rate was shown to be optimal for both rat
and human hepatocytes [11,22,24]. The circuit also contains a
mixing chamber for oxygenation and for the addition or sampling
of media. Because media can be easily withdrawn for analysis and
replenished, one of the main advantages of the inter-connected
system is the possibility of conducting long term or chronic
experiments in different conditions without disturbing the cells. A
peristaltic pump (Ismatech IPC-4, Zurich, Switzerland) and tubing
which connects the various cell chambers were also included in the
circuit. The components of the bioreactor system were sterilised
using H202 gas plasma before each use and assembled under a
laminar flow hood so as to connect the three cell chambers, the
pump, and the mixing chamber via tubing as shown in Figure 1.
Cell Culture
All experiments were carried out using a common medium
which had been previously tested by comparing cell vitality,
morphology and function with respect to the standard media
relative to each cell type [18]. The medium was established as
ECGM containing 10% FBS, and in general EC were shown to be
the most compromised in media other than this. Cells were
incubated with normal (5.5 mM) or high (20 mM) glucose in the
absence or presence of 65 pM insulin dissolved in the common
medium. In order to reduce the number of variables in the
experiments, other hormones known to regulate the energy
balance such as glucagon (important in hypoglycaemic conditions,
which were not included in the present study) and catecholamines
were not included in the media.
The adipose tissue was placed in the Quasi-Vivo chamber and
1 mL medium was added to the chamber. The top of the chamber
was layered with a prewetted 200 micron nylon mesh sandwiched
with 2–40 micron nylon mesh circles in order to prevent
movement of adipocytes out of the chamber and into the tubing
[18]. The ECs were seeded onto a glass coverslip and allowed to
adhere. The coverslip was then placed in the bottom of the LFC.
HEPs were seeded on collagen-coated three dimensional poly-
lactide-co-glycolide scaffolds as described in [22], placed on
12 mm glass coverslips in 24 well microplates (BD Biosciences,
Buccinasco, Italy) at a density of 100,000 cells per scaffold in 2 mL
of ECGM. At 24 h the scaffolds were moved to new 24 multiwell.
After a further 48 hours, when the cells had proliferated to about
250,000 cells per scaffold, the slides were carefully transferred to
the Quasi-Vivo chamber and coated with 250 ml 1% sodium
alginate dissolved in serum free medium and cross linked with
50 ml of 1% CaCl2. The alginate forms a thin permeable coating
over the cells and acts as mechanical barrier against the tangential
shear forces caused by fluid flow.
Adipose tissue, ECs, and HEPs were placed in their respective
chambers and connected together in the ‘‘3-way’’ system. The
common medium was added to the mixing chamber to bring the
total medium volume up to 15 mL and the pump was turned on.
When medium had filled all chambers, the flow was set to
250 mL/min after which the bioreactor was placed inside a 37uC/
5% CO2 incubator. Medium was collected at 15, 24 and 48 H and
assayed to quantify glucose, lactate, FFAs, glycerol, triacylglycer-
ide, albumin, L-alanine, CRP (C-reactive protein), interleukin-6
(IL-6), TNF-a and E-selectin concentrations. At the end of every
experiment cells/tissues were observed under a microscope to
assess cell viability. Control experiments consisted of mono-
cultures in static conditions, in 1-way dynamic cultures and in a
2-way AT-EC configuration, all using the same volume of media.
Cell Viability and Metabolite Dosing
To evaluate the number of adipocytes per unit mass of tissue
and confirm adipocyte viability before and after the experiments,
samples of adipose tissue were further digested with 1 mg/mL
collagenase in HBSS at 37uC for 30 minutes, DMEM medium
containing 10% FBS was added, cells were centrifuged and
floating cells were resuspended in medium. Adipocyte viability was
assessed using CellTiter Blue (Promega, Italia), a colorimetric
indicator of mitochondrial activity. Additionally, adipocytes were
stained with Hoechst 33242 and observed using a fluorescent
microscope (Olympus, AX70, Olympus Italia, Milan) to confirm
nuclear integrity. There was no visible change in the size, nuclear
density or in the appearance of the tissue before and after
incubation and cells remained free of contamination both in the
bioreactor and in static controls. EC and HEP vitality was
measured using CellTiter Blue at the end of each experiment, and
compared with static mono-culture controls. Cell morphology was
also analysed using a microscope and the total cell number for
every time point was evaluated using a Burker chamber and
Figure 1. Schematic of the 3-way connected culture. QV is the low shear Quasi-Vivo chamber for hepatocytes and adipose tissue and LFC is the
high shear laminar flow chamber for endothelial cells. The flow rate used was 250 mL/min. Total circuit volume is 15 mL, with 3 mL of priming volume
per chamber and associated tubing and 6 mL in the mixing chamber and pump.
doi:10.1371/journal.pone.0034704.g001
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trypan blue to exclude non-viable cells. The number of dead cells
counted was always less than 2% of the total.
Glycerol, D-lactate and L-alanine concentrations were deter-
mined by a modified Lloyd assay using an automated spectro-
photometer Cobas Fara II (Roche) [25]. FFAs and glucose were
measured by enzyme assays (NEFA C test-Wako Chemicals
GmbH, Germany and Glucosio HK CP-HoribaABX, Italy
respectively). IL-6, TNF-a, CRP, albumin and E-selectin in the
medium were measured by commercial ELISA kits (Boster
Biological Technology, LDT, Tema Ricerca, Bologna, Italy;
Bethy Laboratories, Montgomery, TX, USA). Triacylglyceride
concentrations in the medium were also assayed (Real Time,
Diagnostic Systems, Viterbo, Italy), but were below the sensitivity
of the kit (1 mg/dl) and were therefore not considered in our
analyses. Similarly CRP and TNF-a concentrations were also
below the limit of detection of the assay kits used in all the
conditions tested (respectively 10 ng/mL and 1 pg/mL).
Statistical Analysis
Statistica Version 7 was used to carry out ANOVA (Analysis of
Variance), student t-tests, and Mann-Whitney tests. Data were
expressed as the mean 6 sd (standard deviation). All experiments
were carriedout at least in triplicate, and thedosingwasperformed in
triplicate. Variations were considered to be significant if the p-value
was ,0.05. Unless noted, the p-values in the text refer to those
obtained from student t-tests. Mann-Whitney and Kruskal-Wallis
analyses confirmed those obtained with t-tests in all cases.
Ethics Statement
Omental adipose tissue was obtained, with written and
informed consent, from surgical interventions in nondiabetic
subjects free of known metabolic disease. Samples were received
and analysed anonymously. The study was approved by the Local
Ethical Committee of the Local Hospital Agency of Padua
(Comitato Etico, Azienda Ospedaliera di Padova).
Results
The 3-way Connected Culture in FS Conditions
The 3-way connected culture of hepatocytes, endothelial cells
and adipose tissue is a simplified in-vitro model of endogenous
metabolism in the visceral region, which resembles the in-vivo
state more closely than traditional cell culture models. Before
culturing the 3 tissues together in the 4 different conditions,
metabolite dynamics and cell viability in static cultures, 1-way
cultures and 2-way (adipose tissue and endothelial cells) cultures
were investigated over a period of 48 hours in the FS condition,
with normal glucose media. For all three cells/tissue, an increase
of viability was observed with respect to static mono-culture
controls (% increases with respect to controls: AT 1063%,
p,0.05, EC 5065% p,0.004, HEP 2563% p,0.001), consistent
with our previous experiments comparing static mono-cultures,
static co-cultures and 2- and 3-way connected cultures
[12,18,26,27]. As discussed therein, the increase in viability in
the 3-way system can be attributed to an increased rate of nutrient
turnover and oxygen supply, an interstitial-like shear stress due to
flow and the presence of cell crosstalk.
The 1, 2 and 3-way metabolite data are summarized in Figure 2
in the form of star plots which represent the fractional change in
metabolite concentration with respect to the initial normal glucose
media concentrations after 48 H (D/0 H value). The 1- and 2-way
cultures were unable to maintain stable glucose, FFA, lactate and
glycerol levels over time. In the 3-way connection, glucose,
glycerol and FFA levels did not change over 48 H, while albumin
synthesis and lactate and L-alanine release were increased with
respect to the 2-way system.
Glucose Dynamics
As shown in Fig. 3A, glucose remained stable over time in the
experiments using normal glucose (FS and PARS) and we did not
observe any effect of insulin on cellular glucose uptake in these
states. On the contrary, at 20 mM glucose, insulin was able to
increase glucose uptake steadily over 48 H, but glucose concen-
trations still remained high after 48 H, dropping by24.8 6
1.3 mM over 48 H in D2 vs. 0.435 6 0.085 mM in D1 (Fig. 3B).
This observation suggests that whilst the 3-way system is adequate
in reversing hypoglycaemia, as shown in Fig. 2B, it is not as
effective in the response to hyperglycaemia, at least in this
experimental setting. In the D1 condition, the response of the
system is similar to what is observed in type 1 diabetics who are
unable to synthesize insulin in response to hyperglycaemia. The
addition of insulin to the system, simulating diabetes type 2,
improved glucose disposal significantly but was not sufficient to
restore normal glucose concentrations, probably because the
insulin dose was quite small, equivalent to a hypoinsulinemic state,
Figure 2. Star plot of measured metabolites in fasting state conditions at 48 H. A) Fractional variation in metabolite concentrations for 1-
way dynamic cultures of AT, EC and HEP (data published in ref. [18]). B) Fractional variation in metabolite concentrations for 2-way (AT+EC) connected
culture and 3-way (AT+EC+HEP) connected culture. GLU (glucose), GLY (glycerol), LAC (lactate), ALA (L-alanine), E-SEL (E-selectin) (data partially
published in ref [12]).
doi:10.1371/journal.pone.0034704.g002
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suggesting that the high levels of glucose provoke a sort of ‘‘insulin
resistance’’ in-vitro. Desensitization to insulin in the presence of
hyperglycaemia in-vitro has been widely documented for many
cell types [28,29] and has also been shown in co-cultures of
adipocytes and hepatocytes [30,31].
FFA and Glycerol Dynamics
In the absence of insulin (FS and D1), FFA was released into the
medium. Insulin significantly (p,0.05) blunted FFA release into
the culture medium in both PARS and D2 conditions (Figs. 3C
and 3D).
Figs. 3E and 3F show a slight glycerol release into the culture
medium over time (0.01060.016 mM in 48 H) in the FS
condition. The addition of insulin, simulating the post absorptive
resting state, prevented this increase. This trend mirrors that of
FFAs. The FS condition is likely characterized by some baseline
lipolysis, which can be blocked by the addition of insulin. On the
other hand we observed a significant decrease in medium glycerol
Figure 3. Glucose, FFA and glycerol in the 3-way cultures in FS, PARS, D1 and D2 conditions. A) Glucose variations over time. B) Changes
in medium glucose concentration with respect to initial media concentration at 48 H (* =p,0.05 vs. D1). C) FFA variations over time. D) Changes in
medium FFA concentration with respect to initial media concentration at 48 H (* = p,0.05 vs. FS; ** = p,0.05 vs. D1). E) Glycerol variations over time.
F) Changes in medium glycerol concentration with respect to initial media concentration at 48 H (* = p,0.05 vs. D1). In all cases time 0 represents the
levels of metabolites in fresh media. Data are expressed as means 6 SD (3#n#6). Error bars represent the standard deviation.
doi:10.1371/journal.pone.0034704.g003
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(20.00660.003 mM in 48 H, p,0.05) in D1, in contrast to what
was observed with FFAs. When insulin was added, extracellular
glycerol increased two-fold (0.01960.003 mM in 48 H). This also
contrasts with the trend of FFAs and demonstrates that high
glucose has divergent effects on FFA and glycerol release, which
can be modulated by the addition of insulin.
Lactate
There was a net increase in medium lactate for all four
conditions (Fig. 4A), with the FS condition showing the highest
cellular lactate release of 1.38660.099 mM over 48 H. The
addition of insulin in the PARS resulted in a lower lactate release
of 1.03960.120 mM over 48 H. A lower level of lactate release
was observed in D1 (1.10460.090 mM over 48 H) with respect to
the fasting state condition. And finally, the addition of insulin to
the high glucose medium resulted in the smallest lactate release
observed, 0.71160.088 mM over 48 H (Fig. 4B). A Pearson’s
Correlation of 20.96 (p,0.05) shows that higher glucose
concentrations correlate with less lactate release suggesting that
changes in the medium glucose concentration can largely explain
total lactate release.
Albumin and Alanine
Albumin is an important marker of hepatic function. Albumin
concentrations were similar in all 4 conditions and consistently
higher than in the 1-way HepG2 monoculture (12.661.2 nM vs.
2.460.2 nM over 48 H, p,0.0001) indicating increased albumin
synthesis and enhanced hepatocyte function in the 3-way system
[18].
A net increase in L-alanine levels was observed over time in all
media (Fig. 4C). In FS, PARS and D1 conditions, similar
quantities of L-alanine were released in the medium. However
in D2, when insulin was added to the high glucose media, L-
alanine levels were almost halved (0.07360.002 mM in D1 vs.
0.035 6 0.005 mM in D2; p= 0.0195) (Fig. 4D). This suggests
that the presence of insulin in the hyperglycaemic media
determined increased amino acid uptake with respect to the other
media.
Cytokines and E-selectin
There was a slight increase in IL-6 levels over time in the FS
condition, and this trend was similar in the PARS (25.8 6 8.7 pg/
mL in FS and 34.56 7.8 pg/mL in PARS over 48 H) (Fig. 5A). In
D1 a net increase in IL-6 was observed at 15 H (from 8.3 6 0.2 to
130 6 9.0 pg/mL, p,0.001). Then, cytokine levels remained
stable over time with a IL-6 release in the medium of 121.7 6
6.6 pg/mL (Fig. 5B). The addition of insulin in D2 significantly
reduced IL-6 levels in the medium over 48 H (34.6 6 6.6,
p,0.0001). Reference IL-6 levels in serum are in the range 0–
25 pg/mL, while higher serum values are characteristic of an
inflammatory status.
As shown in Fig. 5C, in the first 24 H, E-selectin
concentrations did not change significantly under normal glucose
Figure 4. Medium lactate and L-alanine in the 3-way cultures in FS, PARS, D1 and D2 conditions. A) Lactate variations over time. B)
Changes in medium lactate concentration with respect to initial media concentration at 48 H (* = p,0.05 vs. FS; ** = p,0.05 vs. D1). C) L-alanine
variations over time. D) Changes in medium L-alanine concentration with respect to initial media concentration at 48 H (* =p,0.01 vs. D1). In all
cases time 0 represents the levels of metabolites in fresh media. Data are expressed as means 6 SD (3#n#6). Error bars represent the standard
deviation.
doi:10.1371/journal.pone.0034704.g004
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media, both in the FS and PARS conditions. Then, in the
absence of insulin, E-selectin levels dropped at 48 H, while they
remained stable in the PARS (Fig. 5D). Under high glucose
concentrations, in both states D1 and D2, E-selectin increased
significantly within the first 15 H (p,0.009) and then remained
stable. The expression of E-selectin did not change appreciably
with the addition of insulin in D2, indicating that endothelial
stress is due to the high glucose content of the medium. It should
be noted that the levels of E-selectin detected were within the
lower limits of the assay, and certainly much lower than those
typically reported for activated ECs [32,33].
Discussion
Insulin and Glucose Modulation of Metabolite Dynamics:
Parallels with In-vivo States
The data in Figure 2 summarise the differences between 1, 2
and 3 way cultures. When exposed to FS conditions, the 2-way
connected culture of adipose tissue and endothelial cells resulted in
dropping glucose and rising FFA concentrations over time. The
addition of hepatocytes to the culture, forming a 3-way system,
was able to restore normal glucose levels and remove FFAs from
the circulating medium, much as hepatocytes are able to prevent
hypoglycaemia in-vivo by responding to dropping glucose
concentrations with gluconeogenesis [12,18]. When the 3-way
connected culture was exposed to a low dose of insulin with
normal glucose, simulating the post adsorptive resting state,
medium FFA and glycerol decreased over 48 H, suggesting
inhibition of lipolysis, much as lipolysis is inhibited post-prandially
in-vivo, although increased HepG2 hepatocyte FFA uptake cannot
be excluded [34,35]. In fact insulin significantly reduces FFA
release at both normal and high glucose conditions as observed in-
vivo. In the absence of insulin, high glucose may promote adipose
tissue lipolysis and simultaneously inhibit hepatic FFA uptake
[36,37]. The observation of increased FFAs with high glucose in
the absence of insulin, a condition not usually seen in-vivo,
nonetheless brings attention to the fact that hyperglycaemia, in the
absence of adequate insulin, can contribute to high circulating
FFAs, which are associated with other morbidities such as obesity
[38], cardiopathy [39], and atherothrombosis [40].
In contrast to the FFA trend, in the model, insulin had a
glucose-dependent effect on glycerol release. Medium glycerol
levels were reduced in normal glucose media (PARS) and
increased in high glucose media (D2 state) by insulin. Previous
reports on perfused rat adipocytes have shown that insulin can
inhibit FFA release while increasing glycerol release and that
lipolytic oscillations are extremely sensitive to glucose and insulin
concentrations [41].
In humans, lactate levels usually rise after feeding and drop after
fasting. There was net lactate release over 48 H for all conditions
tested, with the D2 state causing a reduction in lactate release. In
the 3-way connection, in FS conditions the observation of lower
lactate release compared with individual monocultures (Figure 2
and ref. [18]), probably represents some hepatic lactate retention
Figure 5. Medium IL-6 and E-selectin in the 3-way cultures in FS, PARS, D1 and D2 conditions. A) IL-6 variations over time. B) Summary of
the changes in Il-6 concentrations over 48 H (* = p,0.05 vs. D1). C) E-selectin variations over time. D) Summary of the changes in E-selectin
concentrations over 48 H (* = p,0.05 vs. FS, ** = p,0.05 vs. D1). Time 0 represents the levels of markers in fresh media. Data are expressed as means
6 SD (3#n#6). Error bars represent the standard deviation.
doi:10.1371/journal.pone.0034704.g005
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to serve as a precursor for gluconeogenesis, followed by glucose
release to replace glucose removed from the medium by ECs and
adipose tissue. In D2, hepatic lactate retention may also fuel
gluconeogenesis, but in this case followed by glycogenesis rather
than glucose release given that extracellular glucose concentrations
remain high despite improved glucose disposal with insulin, which
is known to increase hepatic glycogen synthesis [42].
L-alanine is a precursor of gluconeogenesis and it plays an
important role in maintaining the body’s blood glucose balance. It
is a nonessential amino acid derived from pyruvate transamina-
tion. In the liver alanine is converted back to pyruvate which is a
source for gluconeogenesis. An increase in L-alanine levels was
observed under all four different experimental conditions over
48 H. This may be due to an increase of amino acid synthesis
and/or the conversion of pyruvate by hepatic cells. In normal
glucose media, L-alanine production over 48 H was slightly
decreased by insulin, indicating an increase of protein anabolism.
Inhibition of protein catabolism, possibly associated with increased
protein synthesis, was quite significant (p.0.01) in D2 conditions,
likely due to the action of insulin triggered by high glucose levels.
IL-6 and E-selectin Concentrations are Increased in the
Presence of a Hyperglycaemic Media
Although we did not detect appreciable levels of TNF-a and
CRP in any of our experiments, both IL-6 and E-selectin were
increased in D1 and D2 conditions. In-vivo, muscle-derived IL-6 is
released into the circulation and exerts a glucoregulatory effect on
the liver and adipose tissue. It is involved in other metabolic
pathways, since with the increase in liver glucose output during IL-
6 infusion, Stouthard et al. [43] observed an increased release of
FFAs. Furthermore, infusion of IL-6 into rats increased serum
triacylglyceride and FFA levels in a dose-dependent manner [44].
IL-6 production has also been observed in human adipocytes [45].
In fact, IL-6 was released in the medium in all four different
conditions, but its levels were enhanced in the D1 condition. Here
FFA levels were increased and glucose levels were maintained high
in the medium. This suggests that the IL-6 release mirrors an
oxidative stress and/or inflammation condition of the system
caused by high glucose. The addition of insulin in D2 determined
a drop of glucose and FFAs and in turn a drop of IL-6 levels. The
increase of medium IL-6 release seems to be modulated through
high glucose levels rather than FFAs, since IL-6 levels were
comparable and independent of insulin and FFA content in FS
and PARS conditions.
E-selectin is synthesized and expressed only by activated
endothelial cells and not by other cell types and its presence in
serum should reflect the state of endothelial damage and
regeneration [46]. In our experimental model, we observe an
immediate and consistent increase of E-selectin in the medium in
both D1 and D2 conditions. On the other hand, the normal
glucose concentrations do not induce increased E-selectin release
into the medium, showing that, hypergylcemic conditions can
cause endothelial stress as demonstrated both in-vivo and in-vitro
[47,48].
The most significant results can be summarized in star plot
representing the fractional variation in metabolite or proinflam-
matory marker concentration in the medium at 48 H with respect
to the basal medium concentration (D/0 H value). Figure 6 clearly
illustrates how an imbalance of energetic substrates, in the form of
excess glucose, combined with insufficient insulin, changes the
overall equilibrium or homeostasis of the in-vitro model system
and also induces general as well as specific endothelial stress.
Furthermore, the plot highlights that while small quantities of
insulin are sufficient to contain ‘‘systemic’’ stress levels and FFA
circulation in the medium, these hormone levels have little or no
influence on endothelial injury.
This is the first example of an in-vitro model of endogenous
metabolism which analyses the network of interactions between
different cell types. Despite its apparent simplicity, the 3-way
model has enormous potential as a tool to study the comprehen-
sive effects of different tissues in integrated metabolism. By
connecting three metabolically relevant tissues together and
analyzing metabolite dynamics in different conditions, we
simulated 4 different physiological and pathological conditions
including the fasting state, the post adsorptive state and the post
prandial state in type 1 and type 2 diabetes, respectively. The
results demonstrate that a properly scaled connected culture of
adipose tissue, endothelial cells and hepatocytes can recapitulate
some of the features of human metabolism such as systemic
inflammation in the presence of nutritional overload.
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